Shenzhen Gongjin Electronics Co., Ltd. (SHA:603118)

Marinus Pharmaceuticals Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,038	1,975	2,423	1,576	762.82	476.2
Short-Term Investments	-	100.75	579.75	918.76	1,036	225.45
Trading Asset Securities	800.69	229.84	48.29	-	601.08	1,057
Cash & Short-Term Investments	2,839	2,306	3,051	2,494	2,400	1,758
Cash Growth	42.34%	-24.42%	22.31%	3.92%	36.52%	-21.74%
Accounts Receivable	2,083	1,991	1,995	2,656	2,334	2,455
Other Receivables	12.69	46.8	45.78	76.14	53.3	28.78
Receivables	2,096	2,037	2,041	2,732	2,387	2,484
Inventory	1,422	1,227	1,257	1,497	1,550	1,293
Prepaid Expenses	-	-	-	-	-	0.11
Other Current Assets	168.27	139.5	164.92	297.82	154.38	72.73
Total Current Assets	6,525	5,710	6,514	7,021	6,492	5,608
Property, Plant & Equipment	2,468	2,479	2,766	2,708	2,273	2,163
Long-Term Investments	392.89	397.17	365.32	144.23	106.16	57.04
Goodwill	-	-	-	208.15	477.01	518.45
Other Intangible Assets	241.24	245.8	257.07	269.75	267.5	237.41
Long-Term Deferred Tax Assets	48.68	44.34	36.75	45.62	35.23	32.03
Long-Term Deferred Charges	78.06	80.89	88.64	16.93	34.07	25.39
Other Long-Term Assets	234.61	245.71	186.8	120.05	82.47	94.77
Total Assets	9,988	9,203	10,214	10,534	9,767	8,737
Accounts Payable	1,895	1,958	3,111	3,204	2,777	2,709
Accrued Expenses	83.56	113.94	127.26	183.91	178.98	180.82
Short-Term Debt	2,520	1,790	1,375	1,760	1,678	890.07
Current Income Taxes Payable	26.33	0.95	0.99	21.36	12.72	6.29
Current Unearned Revenue	41.37	43.36	17.29	27.9	31.15	30.45
Other Current Liabilities	394.25	288.72	39.98	101.48	111.81	63.09
Total Current Liabilities	4,960	4,194	4,672	5,299	4,790	3,879
Long-Term Debt	-	-	332.2	27.25	-	-
Long-Term Leases	29.42	29.09	53.69	40.59	-	-
Long-Term Unearned Revenue	10.56	12.54	21.29	17.28	14.59	19.82
Long-Term Deferred Tax Liabilities	-	-	1.54	-	-	-
Other Long-Term Liabilities	2.43	2.18	-	-	-	145.02
Total Liabilities	5,003	4,238	5,081	5,384	4,804	4,044
Common Stock	787.28	787.28	791.46	791.13	792.13	775.73
Additional Paid-In Capital	2,749	2,749	2,751	2,737	2,711	2,665
Retained Earnings	1,457	1,435	1,613	1,650	1,542	1,252
Treasury Stock	-	-	-19.13	-42.11	-74.95	-
Comprehensive Income & Other	-7.9	-6.31	3.56	5.19	-7.17	-4.78
Total Common Equity	4,985	4,965	5,141	5,142	4,963	4,688
Minority Interest	-	-	-6.99	8.13	-0.36	4.54
Shareholders' Equity	4,985	4,965	5,134	5,150	4,963	4,692
Total Liabilities & Equity	9,988	9,203	10,214	10,534	9,767	8,737
Total Debt	2,550	1,819	1,761	1,828	1,678	890.07
Net Cash (Debt)	289.25	487.16	1,290	666.23	722.56	868.11
Net Cash Growth	-37.65%	-62.24%	93.63%	-7.80%	-16.77%	-19.41%
Net Cash Per Share	0.35	0.61	1.59	0.85	0.93	1.13
Filing Date Shares Outstanding	787.28	787.28	791.46	791.13	792.13	775.73
Total Common Shares Outstanding	787.28	787.28	791.46	791.13	792.13	775.73
Working Capital	1,565	1,516	1,842	1,722	1,702	1,729
Book Value Per Share	6.33	6.31	6.50	6.50	6.27	6.04
Tangible Book Value	4,744	4,719	4,884	4,664	4,219	3,932
Tangible Book Value Per Share	6.03	5.99	6.17	5.89	5.33	5.07
Buildings	-	2,071	2,151	2,177	1,796	1,827
Machinery	-	1,263	1,377	1,303	1,224	1,163
Construction In Progress	-	349.85	330.56	260.08	243.21	130.86

Source: S&P Global Market Intelligence. Standard template. Financial Sources.